Research Analysts Issue Forecasts for Pfizer FY2025 Earnings
Pfizer Inc. (NYSE:PFE – Free Report) – Analysts at Cantor Fitzgerald lifted their FY2025 earnings estimates for shares of Pfizer in a research report issued to clients and investors on Wednesday, April 30th. Cantor Fitzgerald analyst C. Gould now anticipates that the biopharmaceutical company will post earnings of $3.10 per share for the year, up […]
